Uptake and subcellular distribution of injected transferrin in rat liver.

H. Goldenberg,M. Eder,R. Pumm,E. Wallner,H. Retzek,M. Hüttinger

DOI: https://doi.org/10.1016/0167-4889(88)90024-9

1988-03-11

Biochimica et Biophysica Acta

Abstract:

What problem does this paper attempt to address?

Excess of circulating apo-transferrin enhances dietary iron absorption

Sofiya Tsyplenkova,Edouard Charlebois,Carine Fillebeen,Kostas Pantopoulos

DOI: https://doi.org/10.1182/blood.2023022916

IF: 20.3

2024-03-27

Blood

Abstract:Intravenous injection of excess apo-transferrin enhances dietary iron absorption in mice, and triggers accumulation of plasma non-transferrin bound iron (NTBI). Injected fluorescent-labeled transferrin colocalizes with lamina propria macrophages, consistent with the recently proposed iron absorption checkpoint involving macrophage-mediated transferrin degradation.

hematology
The role of transferrin receptor 1 and 2 in transferrin-bound iron uptake in human hepatoma cells

Carly E. Herbison,Ketil Thorstensen,Anita C. G. Chua,Ross M. Graham,Peter Leedman,John K. Olynyk,Debbie Trinder

DOI: https://doi.org/10.1152/ajpcell.00649.2008

2009-12-01

Abstract:Transferrin receptor (TFR) 1 and 2 are expressed in the liver; TFR1 levels are regulated by cellular iron levels while TFR2 levels are regulated by transferrin saturation. The aims of this study were to 1) determine the relative importance of TFR1 and TFR2 in transferrin-bound iron (TBI) uptake by HuH7 human hepatoma cells and 2) characterize the role of metal-transferrin complexes in the regulation of these receptors. TFR expression was altered by 1) incubation with metal-transferrin (Tf) complexes, 2) TFR1 and TFR2 small interfering RNA knockdown, and 3) transfection with a human TFR2 plasmid. TBI uptake was measured using 59 Fe- 125 I-labeled Tf and mRNA and protein expression by real-time PCR and Western blot analysis, respectively. Fe 2 Tf, Co 2 Tf, and Mn 2 Tf increased TFR2 protein expression, indicating that the upregulation was not specifically regulated by iron-transferrin but also other metal-transferrins. In addition, Co 2 Tf and Mn 2 Tf upregulated TFR1, reduced ferritin, and increased hypoxia-inducible factor-1α protein expression, suggesting that TFR1 upregulation was due to a combination of iron deficiency and chemical hypoxia. TBI uptake correlated with changes in TFR1 but not TFR2 expression. TFR1 knockdown reduced iron uptake by 80% while TFR2 knockdown did not affect uptake. At 5 μM transferrin, iron uptake was not affected by combined TFR1 and TFR2 knockdown. Transfection with a hTFR2 plasmid increased TFR2 protein expression, causing a 15–20% increase in iron uptake and ferritin levels. This shows for the first time that TFR-mediated TBI uptake is mediated primarily via TFR1 but not TFR2 and that a high-capacity TFR-independent pathway exists in hepatoma cells.
Ferritin: a novel mechanism for delivery of iron to the brain and other organs

J Fisher,K Devraj,J Ingram,B Slagle-Webb,A B Madhankumar,X Liu,M Klinger,I A Simpson,J R Connor

DOI: https://doi.org/10.1152/ajpcell.00599.2006

Abstract:Traditionally, transferrin has been considered the primary mechanism for cellular iron delivery, despite suggestive evidence for additional iron delivery mechanisms. In this study we examined ferritin, considered an iron storage protein, as a possible delivery protein. Ferritin consists of H- and L-subunits, and we demonstrated iron uptake by ferritin into multiple organs and that the uptake of iron is greater when the iron is delivered via H-ferritin compared with L-ferritin. The delivery of iron via H-ferritin but not L-ferritin was significantly decreased in mice with compromised iron storage compared with control, indicating that a feedback mechanism exists for H-ferritin iron delivery. To further evaluate the mechanism of ferritin iron delivery into the brain, we used a cell culture model of the blood-brain barrier to demonstrate that ferritin is transported across endothelial cells. There are receptors that prefer H-ferritin on the endothelial cells in culture and on rat brain microvasculature. These studies identify H-ferritin as an iron transport protein and suggest the presence of an H-ferritin receptor for mediating iron delivery. The relative amount of iron that could be delivered via H-ferritin could make this protein a predominant player in cellular iron delivery.
Optimization of Si slot waveguide using approximate semi-analytical method.

K. Gehlot,A. Sharma

DOI: https://doi.org/10.1364/OE.24.004722

IF: 3.8

2016-03-07

Optics Express

Abstract:The optimization of a slot waveguide for any specific application requires a study of the modal characteristics for a wide range of design parameters. Rigorous numerical methods, such as the finite element method (FEM), are time consuming and require a large amount of memory. In this paper, a simple semi-analytical method is used to analyze silicon slot waveguides and to optimize the performance of the waveguide for maximum power confinement in the slot, minimum effective mode area of the slot and to obtain flat dispersion characteristics. The results obtained by the present method agree well with the rigorous numerical results.
Apotransferrin is Internalized and Distributed in the Same Way As Holotransferrin in K562 Cells

Xl Du,K Wang,L Yuan,Rc Li,Yz Chang,Kp Ho,Zm Qian

DOI: https://doi.org/10.1002/jcp.20051

2004-01-01

Journal of Cellular Physiology

Abstract:Transferrin (Tf), a naturally existing protein, has received considerable attention in the area of drug targeting since it is biodegradable, non-toxic, and nonimmunogenic. The efficient cellular uptake of Tf shows it has potential in the delivery of anti-cancer drugs, proteins, and therapeutic genes into proliferating malignant cells that overexpress transferrin receptor (TfR). In human serum, about 30% of Tf exists in the iron-saturated form (Fe-2-Tf) and the remainder exists as apotransferrin (apo-Tf). Understanding the uptake of apo-Tf by cells will provide key insights into studies on Tf-mediated drug delivery. In the present study, we investigated visually the transport of apo-Tf into K562 cells and its intracellular localization by laser-scanning confocal microscopy (LSCM) and flow cytometry analysis (FCA). It was found that, like Fe-2-Tf, apo-Tf can be taken up into the cells. The process is time- and temperature-dependent, competitively inhibited by Fe-2-Tf, and significantly abolished by pronase pretreatment. Visual evidence showed that the transport of apo-Tf into K562 cells is a TfR-mediated process. Furthermore, the investigations using optical-slicing technique demonstrated that the distribution of apo-Tf is similar to that of Fe-2-Tf, both appearing in the perinuclear region in ball-in-bowl shape.
Duodenal absorption and tissue utilization of dietary heme and nonheme iron differ in rats

Chang Cao,Carrie E Thomas,Karl L Insogna,Kimberly O O'Brien

DOI: https://doi.org/10.3945/jn.114.197939

Abstract:Background: Dietary heme contributes to iron intake, yet regulation of heme absorption and tissue utilization of absorbed heme remains undefined. Objectives: In a rat model of iron overload, we used stable iron isotopes to examine heme- and nonheme-iron absorption in relation to liver hepcidin and to compare relative utilization of absorbed heme and nonheme iron by erythroid (RBC) and iron storage tissues (liver and spleen). Methods: Twelve male Sprague-Dawley rats were randomly assigned to groups for injections of either saline or iron dextran (16 or 48 mg Fe over 2 wk). After iron loading, rats were administered oral stable iron in the forms of (57)Fe-ferrous sulfate and (58)Fe-labeled hemoglobin. Expression of liver hepcidin and duodenal iron transporters and tissue stable iron enrichment was determined 10 d postdosing. Results: High iron loading increased hepatic hepcidin by 3-fold and reduced duodenal expression of divalent metal transporter 1 (DMT1) by 76%. Nonheme-iron absorption was 2.5 times higher than heme-iron absorption (P = 0.0008). Absorption of both forms of iron was inversely correlated with hepatic hepcidin expression (heme-iron absorption: r = -0.77, P = 0.003; nonheme-iron absorption: r = -0.80, P = 0.002), but hepcidin had a stronger impact on nonheme-iron absorption (P = 0.04). Significantly more (57)Fe was recovered in RBCs (P = 0.02), and more (58)Fe was recovered in the spleen (P = 0.01). Conclusions: Elevated hepcidin significantly decreased heme- and nonheme-iron absorption but had a greater impact on nonheme-iron absorption. Differential tissue utilization of heme vs. nonheme iron was evident between erythroid and iron storage tissues, suggesting that some heme may be exported into the circulation in a form different from that of nonheme iron.
Structure, Function and Clinical Significance of Transferrin Receptors

Richard A. Feelders,Ellen P. A. Kuiper-Kramer,Henk G. van Eijk

DOI: https://doi.org/10.1515/cclm.1999.001

1999-01-01

cclm

Abstract:Abstract Iron plays an essential role in a spectrum of metabolic processes. Cellular iron uptake is facilitated by transferrin receptor (TfR)-mediated endocytosis. In recent years more insight has been obtained in TfR physiology and the regulation of cellular iron homeostasis. The synthesis of TfR and the iron storage protein ferritin is regulated reciprocally at the post-transcriptional level according to the cellular iron status. As a result of externalization of TfR during the endocytic cycle, a soluble form of TfR can be detected in serum. The serum TfR (sTfR) level is closely related to erythroid TfR turnover and the prime determinants of the sTfR concentration are cellular iron demands and erythroid proliferation rate. In the absence of a hyperplastic erythropoiesis the sTfR level is a sensitive parameter of early tissue iron deficiency. The entire spectrum of body iron status can be assessed by measurement of serum ferritin and sTfR levels, with ferritin as marker of tissue iron stores and sTfR as index of tissue iron needs. The sTfR may be a promising tool to detect iron deficiency in inflammatory states and in the anaemia of chronic disease as its concentration is, in contrast to ferritin levels, not influenced by the acute phase response. Determination of sTfR levels may also improve assessment of body iron stores during pregnancy and in neonates. Finally, the sTfR may be a useful parameter to monitor erythropoiesis in various clinical settings, for instance in the prediction of the haematological response to erythropoietin treatment. However, standardization of the sTfR assay, with definition of reference and pathological ranges, is necessary for the definitive introduction of the sTfR as major parameter of iron metabolism.
Receptor-mediated endocytosis: The intracellular journey of transferrin and its receptor

Alice Dautry-Varsat

DOI: https://doi.org/10.1016/s0300-9084(86)80004-9

IF: 4.372

1986-03-01

Biochimie

Abstract:A variety of ligands and macromolecules enter cells by receptor-mediated endocytosis. Ligands bind to their receptors on the cell surface and ligand-receptor complexes are localized in specialized regions of the plasma membrane called coated pits. Coated pits invaginate and give rise to intracellular coated vesicles containing ligand-receptor complexes which are thus internalized. Transferrin, a major serum glycoprotein which transports iron into cells, enters cells by this pathway. It binds to its receptor on the cell surface, transferrin-receptor complexes cluster in coated pits and are internalized in coated vesicles. Coated vesicles then lose their clathrin coat and fuse with endosomes, an organelle with an internal pH of about 5-5.5. Most ligands dissociate from their receptors in endosomes and they finally end up in lysosomes where they are degraded, while their receptors remain bound to membrane structures and recycle to the cell surface. Transferrin has a different fate: in endosomes iron dissociates from transferrin but apotransferrin remains bound to its receptor because of its high affinity for the receptor at acid pH. Apotransferrin thus recycles back to the plasma membrane still bound to its receptor. When the ligand-receptor complex reaches the plasma membrane or a compartment at neutral pH, apotransferrin dissociates from its receptor with a half-life of 18 s because of its low affinity for its receptor at neutral pH. The receptor is then ready for a new cycle of internalization, while apotransferrin enters the circulation, reloads iron in the appropriate organs and is ready for a new cycle of iron transport.

biochemistry & molecular biology
Regulation Of Expression Of Murine Transferrin Receptor 2

Hiroshi Kawabata,Rasha S. Germain,Takayuki Ikezoe,Xiangjun Tong,Eric M. Green,Adrian F. Gombart,H. Phillip,Koeffler

DOI: https://doi.org/10.1182/blood.V98.6.1949

IF: 20.3

2001-01-01

Blood

Abstract:Complementary and genomic DNA for the murine transferrin receptor 2 (TfR2) were cloned and mapped to chromosome 5. Northern blot analysis showed that high levels of expression of murine TfR2 occurred in the liver, whereas expression of TfR1 in the liver was relatively low. During liver development, TfR2 was up-regulated and TfR1 was down-regulated. During erythrocytic differentiation of murine erythroleukemia (MEL) cells induced by dim ethyl sulfoxide, expression of TfR1 increased, whereas TfR2 decreased. In MEL cells, expression of TfR1 was induced by desferrioxamine, an iron chelator, and it was reduced by ferric nitrate. In contrast, levels of TfR2 were not affected by the cellular iron status. Reporter assay showed that GATA-1, an erythroid-specific transcription factor essential for erythrocytic differentiation at relatively early stages, enhanced TfR2 promoter activity. Interestingly, FOG-1, a cofactor of GATA-1 required for erythrocyte maturation, repressed the enhancement of the activity by GATA-1. Also, CCAAT-enhancer binding protein, which is abundant in liver, enhanced the promoter activity. Thus, tissue distribution of TfR2 was consistent with the reporter assays. Expression profiles of TfR2 were different from those of TfR1, suggesting unique functions for TfR2, which may be involved in iron metabolism, hepatocyte function, and erythrocytic differentiation.
Determing the biodistribution of nano-Fe2O3-Glu in mice by 59Fe tracer and preparation

Qi-hua YIN,Lu LIU,Ning GU,Ying HUANG,Lan LIU,Jin-hua SONG,Yun CUI

DOI: https://doi.org/10.3969/j.issn.1008-8199.2005.04.008

2005-01-01

Abstract:Objective:To observe the distribution of nano-particles iron oxide in mice ,which is coated with Glu labeled by 59Fe (nano- 59Fe-Fe 2O 3-Glu). Methods:By coprecipitation to synthesis nano- 59Fe- Fe 2O 3-Glu,the distribution in blood, heart, liver, spleen, kidneys ,lungs, brain, eyes and gonad etc are measured, and the character of its pharmacokinetics in vivo is observed,such as the behavior of the absorption, distribution and clearance, accumulation in tissues and the probable target-organ. Results:Nano- 59Fe-Fe 2O 3-Glu,the diameter of which is 15 nm, the maximum in the liver is 48.9%ID/g and the maximum in the spleen 22.9%ID/g at 1 h and 2d respectively after injection of vein of nano- 59Fe-Fe 2O 3-Glu , while in the group of injection of inter-liver the maximum in the liver is 41.3%ID/g、20.8%ID/g、14.6%ID/g at 8 d and the maxium in the spleen is 23.6%ID/g、21.2%ID/g、12.5%ID/g at 24 h in high dose, mid-dose and low dose respectively.There is some radiation in brain ,eyes and gonad ,which indicates nano-Fe 2O 3 may pass through blood brain barrier ,blood testis barrier.The radiation in the blood increases and attains the maximum at 16 d both in the group of injection of vein and in the group of injection of inter-liver, and then it decreased ,but it can also be observed at 48 d. Conclusion:The biological distribution of nano-Fe 2O 3-Glu,which is mainly detained in liver and spleen in vivo, is traced by 59Fe sensitively and accurately, without hemotoxicity and cytotoxicity.
Brain pharmacokinetics of anti-transferrin receptor antibody affinity variants in rats determined using microdialysis

Hsueh-Yuan Chang,Shengjia Wu,Yingyi Li,Wanying Zhang,Matthew Burrell,Carl I. Webster,Dhaval K. Shah

DOI: https://doi.org/10.1080/19420862.2021.1874121

2021-01-01

mAbs

Abstract:Receptor-mediated transcytosis (RMT) is used to enhance the delivery of monoclonal antibodies (mAb) into the central nervous system (CNS). While the binding to endogenous receptors on the brain capillary endothelial cells (BCECs) may facilitate the uptake of mAbs in the brain, a strong affinity for the receptor may hinder the efficiency of transcytosis. To quantitatively investigate the effect of binding affinity on the pharmacokinetics (PK) of anti-transferrin receptor (TfR) mAbs in different regions of the rat brain, we conducted a microdialysis study to directly measure the concentration of free mAbs at different sites of interest. Our results confirmed that bivalent anti-TfR mAb with an optimal dissociation constant (KD) value (76 nM) among four affinity variants can have up to 10-fold higher transcytosed free mAb exposure in the brain interstitial fluid (bISF) compared to lower and higher affinity mAbs (5 and 174 nM). This bell-shaped relationship between KD values and the increased brain exposure of mAbs was also visible when using whole-brain PK data. However, we found that mAb concentrations in postvascular brain supernatant (obtained after capillary depletion) were almost always higher than the concentrations measured in bISF using microdialysis. We also observed that the increase in mAb area under the concentration curve in CSF compartments was less significant, which highlights the challenge in using CSF measurement as a surrogate for estimating the efficiency of RMT delivery. Our results also suggest that the determination of mAb concentrations in the brain using microdialysis may be necessary to accurately measure the PK of CNS-targeted antibodies at the site-of-actions in the brain.

medicine, research & experimental
Membrane transport of non-transferrin-bound iron by reticulocytes

E H Morgan

DOI: https://doi.org/10.1016/0005-2736(88)90374-4

1988-09-01

Abstract:The transport of non-transferrin-bound iron into rabbit reticulocytes was investigated by incubating the cells in 0.27 M sucrose with iron labelled with 59Fe. In most experiments the iron was maintained in the reduced state, Fe(II), with mercaptoethanol. The iron was taken up by cytosolic, haem and stromal fractions of the cells in greater amounts than transferrin-iron. The uptake was saturable, with a Km value of approx. 0.2 microM and was competitively inhibited by Co2+, Mn2+, Ni2+ and Zn2+. It ceased when the reticulocytes matured into erythrocytes. The uptake was pH and temperature sensitive, the pH optimum being 6.5 and the activation energy for iron transport into the cytosol being approx. 80 kJ/mol. Ferric iron and Fe(II) prepared in the absence of reducing agents could also be transported into the cytosol. Sodium chloride inhibited Fe(II) uptake in a non-competitive manner. Similar degrees of inhibition was found with other salts, suggesting that this effect was due to the ionic strength of the solution. Iron chelators inhibited Fe(II) uptake by the reticulocytes, but varied in their ability to release 59Fe from the cells after it had been taken up. Several lines of evidence showed that the uptake of Fe(II) was not being mediated by transferrin. It is concluded that the reticulocyte can transport non-transferrin-bound iron into the cytosol by a carrier-mediated process and the question is raised whether the same carrier is utilized by transferrin-iron after its release from the protein.
The transferrin receptor: role in health and disease

Prem Ponka,Chun Nam Lok

DOI: https://doi.org/10.1016/s1357-2725(99)00070-9

1999-10-01

Abstract:The transferrin receptor is a membrane glycoprotein whose only clearly defined function is to mediate cellular uptake of iron from a plasma glycoprotein, transferrin. Iron uptake from transferrin involves the binding of transferrin to the transferrin receptor, internalization of transferrin within an endocytic vesicle by receptor-mediated endocytosis and the release of iron from the protein by a decrease in endosomal pH. With the exception of highly differentiated cells, transferrin receptors are probably expressed on all cells but their levels vary greatly. Transferrin receptors are highly expressed on immature erythroid cells, placental tissue, and rapidly dividing cells, both normal and malignant. In proliferating nonerythroid cells the expression of transferrin receptors is negatively regulated post-transcriptionally by intracellular iron through iron responsive elements (IREs) in the 3' untranslated region of transferrin receptor mRNA. IREs are recognized by specific cytoplasmic proteins (IRPs; iron regulatory proteins) that, in the absence of iron in the labile pool, bind to the IREs of transferrin receptor mRNA, preventing its degradation. On the other hand, the expansion of the labile iron pool leads to a rapid degradation of transferrin receptor mRNA that is not protected since IRPs are not bound to it. However, some cells and tissues with specific requirements for iron probably evolved mechanisms that can override the IRE/IRP-dependent control of transferrin receptor expression. Erythroid cells, which are the most avid consumers of iron in the organism, use a transcriptional mechanism to maintain very high transferrin receptor levels. Transcriptional regulation is also involved in the receptor expression during T and B lymphocyte activation. Macrophages are another example of a cell type that shows 'unorthodox' responses in terms of IRE/IRP paradigm since in these cells elevated iron levels increase (rather than decrease) transferrin receptor mRNA and protein levels. Erythroid cells contain the highest mass of the total organismal transferrin receptors which are released from reticulocytes during their maturation to erythrocytes. Hence, plasma contains small amounts of transferrin receptors which represent a soluble fragment of the extracellular receptor domain. Measurements of serum transferrin receptor concentrations are clinically useful since their levels correlate with the total mass of immature erythroid cells.
Use Of Primary Rat Hepatocytes In The Gel Entrapment Culture To Predict In Vivo Biliary Excretion

Jian Yin,Qin Meng

DOI: https://doi.org/10.3109/00498254.2011.633716

2012-01-01

Abstract:1. In vitro models have been widely used in characterizing the hepatobiliary elimination of compounds. However, the application of in vitro models is often limited by their imperfect simulation of in vivo situations. The current paper aims to introduce the gel entrapment culture of rat hepatocytes as an alternative method for measuring hepatobiliary transport, with the sandwich culture of rat hepatocytes set as the control.2. First, the culture conditions of the gel-entrapped hepatocytes were modified to enhance hepatic transport function. When cultured under optimal conditions, i.e. the collagen concentration was set to 0.6 mg/mL and the regular Williams' E medium was supplemented with epidermal growth factor, the hepatocytes maintained much higher hepatic transporter gene expression levels and transport activities than that in regular gel entrapment and sandwich culture.3. Compared with the actual values in rats, the predicted intrinsic biliary clearance (CLbile,int,predicted) of the 10 model compounds in the optimized gel entrapment culture showed a high correlation coefficient squared (R-2) of 0.94, with the majority falling within the two-fold error range of the in vivo values, which was much better than the comparable sandwich culture.4. All of these results indicate that the optimized gel entrapment culture of hepatocytes is a suitable approach for estimating in vivo biliary excretion.
Transferrin and transferrin receptors update

Hiroshi Kawabata

DOI: https://doi.org/10.1016/j.freeradbiomed.2018.06.037

IF: 8.101

2019-03-01

Free Radical Biology and Medicine

Abstract:In vertebrates, transferrin (Tf) safely delivers iron through circulation to cells. Tf-bound iron is incorporated through Tf receptor (TfR) 1-mediated endocytosis. TfR1 can mediate cellular uptake of both Tf and H-ferritin, an iron storage protein. New World arenaviruses, which cause hemorrhagic fever, and Plasmodium vivax use TfR1 for entry into host cells. Human TfR2, another receptor for Tf, is predominantly expressed in hepatocytes and erythroid precursors, and holo-Tf dramatically upregulates its expression. TfR2 forms a complex with hemochromatosis protein, HFE, and serves as a component of the iron sensing machinery in hepatocytes. Defects in TfR2 cause systemic iron overload, hemochromatosis, through down-regulation of hepcidin. In erythroid cells, TfR2 forms a complex with the erythropoietin receptor and regulates erythropoiesis. TfR2 facilitates iron transport from lysosomes to mitochondria in erythroblasts and dopaminergic neurons. Administration of apo-Tf, which scavenges free iron, has been explored for various clinical conditions including atransferrinemia, iron overload, and tissue ischemia. Apo-Tf has also been shown to ameliorate anemia in animal models of β-thalassemia. In this review, I provide an update and summary on our knowledge of mammalian Tf and its receptors.

biochemistry & molecular biology,endocrinology & metabolism
Paraferritin: a protein complex with ferrireductase activity is associated with iron absorption in rats

J N Umbreit,M E Conrad,E G Moore,M P Desai,J Turrens

DOI: https://doi.org/10.1021/bi951927s

IF: 3.321

1996-05-21

Biochemistry

Abstract:Recent studies reported that iron salts were absorbed in the duodenum utilizing a pathway involving membrane-associated integrin and a cytosolic protein named mobilferrin. In addition, a large molecular weight cytoplasmic complex was labeled with radioiron during mucosal uptake of iron in the duodenum. The molecular mass of this protein was 520 000 daltons, slightly larger than ferritin. On denaturing SDS-PAGE, the purified protein complex appeared to consist of at least four polypeptides, closely associated with each other. This complex was called paraferritin because its hydrodynamic volume resembled ferritin. In the present work, antibody studies demonstrate the presence of integrin, mobilferrin, and flavin monooxygenase in the water-soluble complex. Biochemical studies demonstrate the presence of a NADPH-dependent flavin monooxygenase ferrireductase activity that reduces Fe(III) to Fe(II). Antibodies against either integrin or mobilferrin inhibit monooxygenase activity. Inhibition of monooxygenase activity decreases radioiron uptake by tissue culture intestinal cells. Thus, we postulated that paraferritin plays a role in the mucosal uptake and transport of inorganic iron in small intestinal absorptive cells and is a mechanism for both the internalization of integrin from membranes to cellular cytosol and the delivery of iron to cellular constituents in an appropriate redox state.
Effects of Exogenous Transferrin on the Regulation of Iron Metabolism and Erythropoiesis in Iron Deficiency With or Without Anemia

Yihang Li,Ian Miller,Princy Prasad,Nisha Ajit George,Nermi L. Parrow,Robert E. Fleming

DOI: https://doi.org/10.3389/fphys.2022.893149

IF: 4

2022-05-12

Frontiers in Physiology

Abstract:Erythropoietic response is controlled not only by erythropoietin but also by iron. In addition to its role in iron delivery, transferrin also functions as a signaling molecule, with effects on both iron homeostasis and erythropoiesis. We investigated hematologic parameters, iron status and expression of key proteins, including the hepatic iron regulatory protein hepcidin and the suppressive erythroid factor Erfe , in mice subject to dietary iron deficiency with and without anemia. The acute effect of iron on these parameters was investigated by administration of exogenous iron-loaded transferrin (holoTf) in each of the mouse models. Serum iron in mice with iron deficiency (ID) is modestly lower with hematologic parameters maintained by utilization of iron stores in mice with ID. As expected, erythropoietin expression and concentration, along with marrow Erfe are unaffected in ID mice. Administration of holoTf restores serum iron and Tf saturation levels to those observed in control mice and results in an increase in hepcidin compared to ID mice not treated with holoTf. The expression of the Bmp signaling molecule Bmp6 is not significantly increased following Tf treatment in ID mice. Thus, the expression level of the gene encoding hepcidin, Hamp1 , is increased relative to Bmp6 expression in ID mice following treatment with holoTf, leading us to speculate that Tf saturation may influence Bmp sensitivity. In mice with iron deficiency anemia (IDA), decreased hematologic parameters were accompanied by pronounced decreases in serum and tissue iron concentrations, and an increase in serum erythropoietin. In the absence of exogenous holoTf, the greater serum erythropoietin was not reflected by an increase in marrow Erfe expression. HoloTf administration did not acutely change serum Epo in IDA mice. Marrow Erfe expression was, however, markedly increased in IDA mice following holoTf, plausibly accounting for the lack of an increase in Hamp1 following holoTf treatment in the IDA mice. The increase in Erfe despite no change in erythropoietin suggests that Tf acts to increase erythropoietin sensitivity. These observations underscore the importance of Tf in modulating the erythropoietic response in recovery from iron deficiency anemia, with implications for other stress erythropoiesis conditions.

physiology
Immunoregulation of IgE responses: the role of the gut in perspective.

E. Jarrett

Abstract:In adult rats and mice of most strains the experience of antigen whether by mouth or by injection usually leads to a diminished rather than a heightened IgE response to a subsequent exposure. This is because these animals have a highly developed capacity to suppress the production of IgE by immunoregulatory mechanisms which can be activated by the administration of even minute quantities of antigen. The situation in young animals is less clear but there are indications that the suppressive mechanisms are less well developed. However, recent experiments in rats have shown that a relatively long lasting suppression of IgE responsiveness occurs in the offspring of immunized mothers and that this effect is mediated by maternal IgG. In this way, the influence of the immunized mother can be seen to compensate for any deficiencies of the developing immunoregulatory mechanisms of the young animal. These experiments were designed to explore ideas about the physiological regulation of IgE responses.
Empirical approach to predict leached nutrients from landfill site

P. Barman,S. Kartha,B. Pradhan

DOI: https://doi.org/10.1007/s11356-014-3844-1

2015-05-01

Environmental Science and Pollution Research International

Abstract:
Structural and functional characterization of recombinant human serum transferrin secreted from Pichia pastoris

Kimihiko Mizutani,Kazuhiko Hashimoto,Nobuyuki Takahashi,Masaaki Hirose,Shigeo Aibara,Bunzo Mikami

DOI: https://doi.org/10.1271/bbb.90635

Abstract:Serum transferrin is an iron-binding glycoprotein with a bilobal structure. It binds iron ions in the blood serum and delivers them into target cells via transferrin receptor. We identified structural and functional characteristics of recombinant human transferrin which is produced in the yeast Pichia pastoris. Using the signal sequence of the alpha factor of the yeast Saccharomyces cerevisiae, high-level secretion was obtained, up to 30 mg/l of culture medium. Correct processing at designed sites was confirmed by N-terminal sequence analysis. Carbohydrate modification was determined by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) analysis after digestion with endo-beta-N-acetylglucosaminidase H. Reflecting the secondary structure, the circular dichroism spectrum of the recombinant protein was indistinguishable from that of serum transferrin. Consequently, the recombinant product had an iron binding function just as the serum specimen has: two Fe(3+) sites existed in a recombinant transferrin molecule, as estimated by titration analysis using visible absorption, fluorescence spectra, and electrophoretic behavior in urea denaturing polyacrylamide gel electrophoresis (PAGE).

Uptake and subcellular distribution of injected transferrin in rat liver.

Excess of circulating apo-transferrin enhances dietary iron absorption

The role of transferrin receptor 1 and 2 in transferrin-bound iron uptake in human hepatoma cells

Ferritin: a novel mechanism for delivery of iron to the brain and other organs

Optimization of Si slot waveguide using approximate semi-analytical method.

Apotransferrin is Internalized and Distributed in the Same Way As Holotransferrin in K562 Cells

Duodenal absorption and tissue utilization of dietary heme and nonheme iron differ in rats

Structure, Function and Clinical Significance of Transferrin Receptors

Receptor-mediated endocytosis: The intracellular journey of transferrin and its receptor

Regulation Of Expression Of Murine Transferrin Receptor 2

Determing the biodistribution of nano-Fe2O3-Glu in mice by 59Fe tracer and preparation

Brain pharmacokinetics of anti-transferrin receptor antibody affinity variants in rats determined using microdialysis

Membrane transport of non-transferrin-bound iron by reticulocytes

The transferrin receptor: role in health and disease

Use Of Primary Rat Hepatocytes In The Gel Entrapment Culture To Predict In Vivo Biliary Excretion

Transferrin and transferrin receptors update

Paraferritin: a protein complex with ferrireductase activity is associated with iron absorption in rats

Effects of Exogenous Transferrin on the Regulation of Iron Metabolism and Erythropoiesis in Iron Deficiency With or Without Anemia

Immunoregulation of IgE responses: the role of the gut in perspective.

Empirical approach to predict leached nutrients from landfill site

Structural and functional characterization of recombinant human serum transferrin secreted from Pichia pastoris